Amid the chaos of an epidemic, those who survive a disease like COVID-19 carry within their bodies the secrets of an effective immune response. Virologists like me look to survivors for molecular clues that can provide a blueprint for the design of future treatments or even a vaccine.
On Sunday, August 23, President Donald Trump is expected to announce at The White House that convalescent plasma will be given emergency use authorization to treat COVID-19, something Trump has called a “major therapeutic breakthrough,” CNN reports.